BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34231629)

  • 1. Novel semiconducting nano-agents incorporating tirapazamine for imaging guided synergistic cancer hypoxia activated photo-chemotherapy.
    Zhang G; Wang W; Zou H; Wei Z; Song C; Ran J; Cao Z; Cai Y; Han W
    J Mater Chem B; 2021 Jul; 9(26):5318-5328. PubMed ID: 34231629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
    Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
    J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
    Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupick√Ĺ D
    ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy.
    Qu J; Teng D; Sui G; Guan S; Wang Y; Wang Q; Lin Y; Ran H; Wang Z; Wang H
    Biomater Sci; 2020 Jun; 8(11):3116-3129. PubMed ID: 32352102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
    Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J
    Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A triple-stimulus responsive melanin-based nanoplatform with an aggregation-induced emission-active photosensitiser for imaging-guided targeted synergistic phototherapy/hypoxia-activated chemotherapy.
    Yu J; Zhang X; Pei Z; Shuai Q
    J Mater Chem B; 2021 Nov; 9(44):9142-9152. PubMed ID: 34693960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune remodeling triggered by photothermal therapy with semiconducting polymer nanoparticles in combination with chemotherapy to inhibit metastatic cancers.
    Yang Y; Xu M; Wang Z; Yang Y; Liu J; Hu Q; Li L; Huang W
    J Mater Chem B; 2021 Mar; 9(11):2613-2622. PubMed ID: 33683252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles.
    Wang H; Zhang C; Zhang Y; Tian R; Cheng G; Pan H; Cui M; Chang J
    J Mater Chem B; 2020 Apr; 8(14):2876-2886. PubMed ID: 32191252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation.
    Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L
    Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
    Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
    Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles.
    Huang X; Wu J; He M; Hou X; Wang Y; Cai X; Xin H; Gao F; Chen Y
    Mol Pharm; 2019 May; 16(5):2172-2183. PubMed ID: 30978027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H
    Qiao L; Ou Y; Li L; Wu S; Guo Y; Liu M; Yu D; Chen Q; Yuan J; Wei C; Ou C; Li H; Cheng D; Yu Z; Li Z
    J Nanobiotechnology; 2024 Apr; 22(1):205. PubMed ID: 38658965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan-fullerene/AIEgen nanogel as CD44-targeted delivery of tirapazamine for synergistic photodynamic-hypoxia activated therapy.
    Hong X; Xu X; Liu Z; Liu S; Yu J; Wu M; Ma Y; Shuai Q
    Nanotechnology; 2021 Aug; 32(46):. PubMed ID: 34325415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized Combination of Photodynamic Therapy and Chemotherapy Using Gelatin Nanoparticles Containing Tirapazamine and Pheophorbide a.
    Lee D; Jang SY; Kwon S; Lee Y; Park E; Koo H
    ACS Appl Mater Interfaces; 2021 Mar; 13(9):10812-10821. PubMed ID: 33624503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
    Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
    J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy.
    Yang Y; Yang X; Li H; Li C; Ding H; Zhang M; Guo Y; Sun M
    Colloids Surf B Biointerfaces; 2019 Jan; 173():564-570. PubMed ID: 30347383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses.
    Ma B; Sheng J; Wang P; Jiang Z; Borrathybay E
    Int J Nanomedicine; 2019; 14():4541-4558. PubMed ID: 31417257
    [No Abstract]   [Full Text] [Related]  

  • 18. Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
    Guo D; Xu S; Yasen W; Zhang C; Shen J; Huang Y; Chen D; Zhu X
    Biomater Sci; 2020 Jan; 8(2):694-701. PubMed ID: 31777870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light-triggered theranostic liposomes for tumor diagnosis and combined photodynamic and hypoxia-activated prodrug therapy.
    Zhang K; Zhang Y; Meng X; Lu H; Chang H; Dong H; Zhang X
    Biomaterials; 2018 Dec; 185():301-309. PubMed ID: 30265899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapy.
    Chen H; Fu Y; Feng K; Zhou Y; Wang X; Huang H; Chen Y; Wang W; Xu Y; Tian H; Mao Y; Wang J; Zhang Z
    J Nanobiotechnology; 2021 Sep; 19(1):298. PubMed ID: 34592996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.